NCT01000025 2023-08-22PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic CancerCanadian Cancer Trials GroupPhase 3 Completed720 enrolled 14 charts